Compare tumor PDOs, normal-tissue organoids and disease models by project goal, available assays and collaboration format. Browse options for supplied models, TRiCBIO-run studies and custom development.
For inflammatory bowel disease (IBD), established inflammation and barrier assays in mouse intestinal organoids support candidate comparison across morphology, permeability, viability and F-actin/ZO-1; we tailor a human study to the sample and program goal.
For autosomal dominant polycystic kidney disease (ADPKD), characterized hPSC-derived kidney organoids provide the starting point for cyst phenotypes, PKD-related assays, candidate-intervention conditions, QC and deliverables.
Compare tumor PDOs, normal-tissue organoids and disease models by project goal, available assays and collaboration format. Browse options for supplied models, TRiCBIO-run studies and custom development.
For inflammatory bowel disease (IBD), established inflammation and barrier assays in mouse intestinal organoids support candidate comparison across morphology, permeability, viability and F-actin/ZO-1; we tailor a human study to the sample and program goal.
For autosomal dominant polycystic kidney disease (ADPKD), characterized hPSC-derived kidney organoids provide the starting point for cyst phenotypes, PKD-related assays, candidate-intervention conditions, QC and deliverables.